Ignite Creation Date:
2025-12-25 @ 12:05 AM
Ignite Modification Date:
2025-12-25 @ 10:04 PM
Study NCT ID:
NCT00970658
Status:
UNKNOWN
Last Update Posted:
2009-09-04
First Post:
2009-09-01
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Salonsip Compared to Sabiá Plaster
Sponsor:
Hisamitsu Farmaceutica do Brasil Ltda
Organization:
Study Overview
Official Title:
Clinical Multicenter Study, Randomized, Open, to Evaluate the Efficacy and Safety of Salonsip Compared to Sabiá Plaster Relief of the Signs and Symptoms in Patients With Contusions, Sprains, Injuries and Muscular Injuries With Less Than 24 Hours Early or Holders of Myalgia, Pain and Tendonitis in Regions Miofasciais Articulated.
Status:
UNKNOWN
Status Verified Date:
2009-09
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
SAL-SIP-03/09
Brief Summary:
The purpose of this study is to evaluate the efficacy in reducing signs and symptoms in patients with contusions, sprains, muscular injuries and injuries with less than 24 hours early or holders of myalgia, pain and tendonitis in regions miofasciais articulated with Salonsip compared to Sabiá plaster.
It is clinical, open, multicenter, randomized, prospective and comparative, with patients entering at random.
Patients will be included in sufficient quantity to achieve the minimum number of 70 evaluable patients.
It is clinical, open, multicenter, randomized, prospective and comparative, with patients entering at random.
Patients will be included in sufficient quantity to achieve the minimum number of 70 evaluable patients.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: